Clinical Trial Update: Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of Oravescent fentanyl citrate for breakthrough pain in chronic neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• OraVescent Fentanyl Citrate (fentanyl citrate)

Snippet

Sponsor: Cephalon | Conditions: Chronic Neuropathic Pain | Phase 3 | Status: COMPLETED